Publikationen, an denen er mitarbeitet Juan Francisco Navarro González (10)

2023

  1. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

2022

  1. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

  2. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

2021

  1. Epigenetic regulation of KLOTHO in peripheral blood circulating cells is associated with soluble protein serum levels in cardiovascular disease

    Atherosclerosis, Vol. 331, pp. e223

  2. KLOTHO gene promoter methylation in the vasculature is related to inflammation in human atherosclerosis

    Atherosclerosis, Vol. 331, pp. e222

  3. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia

    Rheumatology (Oxford, England), Vol. 60, Núm. 1, pp. 371-379

2020

  1. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus

    Journal of Clinical Medicine, Vol. 8, Núm. 4, pp. 448

  2. Fibroblast growth factor 23 expression in human calcified vascular tissues

    Aging, Vol. 11, Núm. 18, pp. 7899-7913

  3. Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

    Journal of Clinical Medicine, Vol. 8, Núm. 3